Eur J Hosp Pharm 19:545-546 doi:10.1136/ejhpharm-2012-000229
  • Country focus: Denmark

Morphine: oxycodone interventions in Denmark

  1. Stig Ejdrup Andersen2
  1. 1Medical Information Centre, The Capital Region of Denmark Hospital Pharmacy, Bispebjerg Hospital, Copenhagen, Denmark
  2. 22Department of Clinical Pharmacology, Bispebjerg Hospital, Copenhagen, Denmark
  1. Correspondence to Camilla Munk Mikkelsen, Region Hovedstaden Apotek, Apotekets Information, Bispebjerg Hospital, Bispebjerg Bakke 23 opg. 51, 2. sal, 2400 København NV, Denmark
  • Received 12 September 2012
  • Revised 22 October 2012
  • Accepted 25 October 2012

In the years of the late 2000s, the use of oxycodone in both primary care and hospital care increased significantly in Denmark while the use of morphine decreased. Although oxycodone and morphine are considered equally effective and safe, oxycodone is much more expensive than morphine. Therefore, morphine is more cost effective than oxycodone. In primary care, in particular, the price of oxycodone is about 2–3 times higher than that of morphine.

Public health insurance in Denmark pays up to 80% of the medication costs for patients in primary care and the regions pays all costs for patients in hospital care. On this basis, it is economically very important that drug use in both sectors …

EJHP blog

Analysis and discussion of the latest news, research findings and policy developments in hospital pharmacy.

Visit the blog >>

Free Sample

This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of EJHP.

View free sample issue >>

Email alerts

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Navigate This Article